Clinicopathological and molecular predictors of [(18)F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial
HER2阳性早期乳腺癌中[(18)F]FDG-PET疾病检测的临床病理学和分子预测因子:RESPONSE,一项随机PHERGain试验的子研究
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06683-0
Llombart-Cussac, Antonio; Prat, Aleix; Pérez-García, José Manuel; Mateos, José; Pascual, Tomás; Escrivà-de-Romani, Santiago; Stradella, Agostina; Ruiz-Borrego, Manuel; de Las Heras, Begoña Bermejo; Keyaerts, Marleen; Galvan, Patricia; Brasó-Maristany, Fara; García-Mosquera, Juan José; Guiot, Thomas; Gion, María; Sampayo-Cordero, Miguel; Di Cosimo, Serena; Pérez-Escuredo, Jhudit; de Frutos, Manuel Atienza; Cortés, Javier; Gebhart, Geraldine